XC Interspinous Spacer I (Titanium)

Lumbar spinal stenosis with neurogenic claudication is the primary clinical setting for this device, used in patients who have not responded adequately to conservative treatment but may not be suitable candidates for, or may wish to avoid, more invasive decompression or fusion surgery at the affected level. Procurement governance matters here as much as clinical fit: NHS spine units evaluating minimally invasive stenosis treatment options need this device stocked reliably across the confirmed size range, which is where Medigearuk's role as a stocking supplier matters to tender decisions and theatre list planning.

Patients with significant medical comorbidities form a second important clinical setting, where general clinical literature notes that the minimally invasive nature of interspinous spacer implantation, in some cases performed under local anaesthesia, may suit patients less able to tolerate open surgery or general anaesthesia and its associated risks.

Ambulatory and day-case surgical settings represent a third important clinical setting, where general literature describes interspinous spacer implantation as suited to same-day procedures in appropriate patients, distinct from the longer recovery typically associated with open decompression or fusion surgery.

Patients seeking a treatment option between conservative care and open surgery make up a fourth important clinical setting, where general clinical literature positions interspinous spacers as addressing a gap in the continuum of care for moderate lumbar spinal stenosis. Medigear.uk supports single or small-quantity ordering of this device alongside the bulk distributor accounts it also serves, so a specialist clinic is not required to commit to trust-scale volumes to access it.

Genuinely Distinct, Well-Established Device Category

Interspinous spacers are a well-documented device category in spine surgery, with a substantial published evidence base including randomised trials, distinct from the fusion and interbody devices covered elsewhere in this catalogue.

Minimally Invasive Implantation

General clinical literature describes interspinous spacer implantation as less invasive than direct decompression procedures such as laminectomy, in some cases performed under local anaesthesia in an ambulatory setting.

Six Sizes for Anatomical Fit

Sizes from 6mm to 16mm let a surgeon select the spacer suited to the specific interspinous space and degree of distraction required.

Indirect Decompression Without Bone or Tissue Removal

General literature describes the extension-blocking mechanism as achieving decompression without directly removing bone or ligament, distinct from open decompression technique.

ISO 13485-Certified Manufacturing for Procurement Governance

XC's quality management system is certified to ISO 13485 at the company level, giving hospital procurement teams and distributors a documented baseline to evaluate against tender requirements. Buyers should confirm CE marking status for this specific reference before submitting to formal procurement processes.

Titanium Construction

The device is manufactured from titanium, consistent with the biocompatibility and radiopacity generally associated with implantable spinal devices in clinical literature.

REF-Coded Ordering for Simplified Procurement

Each size is ordered under its own REF code, giving procurement teams a clear, unambiguous way to specify the exact device needed against a surgeon's preoperative plan.

Small-Batch Ordering for Specialist Clinics and Independent Practices

Independent spine surgeons and smaller private surgical centres do not always need trust-scale order volumes, and Medigear.uk supports single or small-quantity purchasing of this device alongside its larger distributor accounts.

6mm and 8mm Sizes

The smallest confirmed sizes, suited to narrower interspinous spaces.

10mm and 12mm Sizes

Mid-range confirmed sizes.

14mm and 16mm Sizes

The largest confirmed sizes, suited to wider interspinous spaces.

Titanium Construction

Manufactured from titanium, consistent with general interspinous spacer device design.

REF-Coded Ordering System

Each size carries its own REF code, providing a clear, unambiguous way to specify the exact device needed for a given order.

Extension-Blocking Mechanism

General literature describes this device category as limiting spinal extension at the treated level, indirectly decompressing the neural foramina and central canal.

Distinct Product Category from XC's Fusion and Interbody Devices

Implanted between adjacent spinous processes rather than within the disc space or in place of a vertebral body, a genuinely different clinical application from other products in this catalogue.

Minimally Invasive Implantation Technique

General literature describes this device category as suited to minimally invasive implantation, in some cases under local anaesthesia.

Established General Literature Base

Supported by a substantial published evidence base including randomised trials for the device category generally, though outcome data specific to this exact XC reference has not been confirmed.

Suited to Patients Between Conservative Care and Open Surgery

General literature positions this device category as addressing a treatment gap for patients who have exhausted conservative care but may not want or tolerate more invasive surgery.

Six Confirmed Sizes Spanning a Broad Range

From 6mm to 16mm, giving procurement teams a reasonably broad confirmed range for anatomical fit.

Ambulatory Setting Compatibility

General literature describes this device category as compatible with same-day ambulatory procedures in appropriate patients.

The XC Interspinous Spacer (Titanium) is a minimally invasive device available in six sizes, 6mm to 16mm, under REF codes beginning KTJT, designed for indirect decompression of lumbar spinal stenosis. It is a genuinely distinct product category from XC's fusion and interbody devices covered elsewhere in this catalogue, suited to patients with neurogenic claudication who have not responded to conservative care, patients with significant comorbidities, and ambulatory or day-case surgical settings. XC's ISO 13485-certified manufacturing gives procurement teams a documented baseline for evaluation, and a substantial general clinical literature base supports the interspinous spacer device category broadly. However, confirm CE marking status and outcome data specific to this exact XC reference with Medigear.uk before tender. Contact Medigear.uk for specifications, procurement assistance, or expert consultation.